Tirzepatide (Mounjaro)
A dual GIP and GLP-1 agonist, and the most effective weight-loss molecule currently available in India. Read the trial evidence, the dose ladder and the honest side-effect numbers.
Read the guideDoctor-led · Holistic care
Medical Weight Loss
Explore the wide range of prescription weight-loss medicine and GLP-1 support program to help you get the best result from GLP-1's. The program includes health coach and doctor support through out the program.
- NMC-registered doctors
- Licensed partner pharmacy
- Discreet delivery
- No hidden charges
- GLP-1 Support Program Monthly: view details
GLP-1 Support Program Monthly
FromRs. 2,999.00 - GLP-1 Doctor Consultation | Internal Medicine Specialist: view detailsStart here
GLP-1 Doctor Consultation | Internal Medicine Specialist
Rs. 599.00
Every GLP-1 medicine in India, explained honestly
Doctor-reviewed guides to each medicine we work with: how it works, what the trials actually showed, the real side-effect rates and who it suits. These pages are information, not a shop — nothing is sold from them, and which medicine is right for you is a decision for your doctor.
-
-
Wegovy (semaglutide)
Novo Nordisk's obesity-indicated semaglutide, and the formulation behind the STEP and SELECT trials. The full 0.25 to 2.4 mg ladder, with the cardiovascular outcome data explained.
Read the guide -
Semaglutide generics
Since the patent expired in March 2026, the same molecule is sold in India under more than twenty names by Sun Pharma, Eris, Alkem and Zydus. What separates them, and what the difference between them actually means for you.
Compare the brands -
Ozempic (semaglutide)
Novo Nordisk's original semaglutide for type 2 diabetes, launched in India in December 2025. The SUSTAIN-6 cardiovascular and FLOW kidney outcome data, and how it differs from Wegovy.
Read the guide -
Poviztra (Emcure)
Novo Nordisk's second brand of Wegovy, distributed exclusively in India by Emcure. The original molecule, carried up to the full 2.4 mg maintenance dose.
Read the guide -
Extensior (Abbott)
Abbott India's brand of Novo Nordisk semaglutide, and a second brand of Ozempic. Indicated for type 2 diabetes, with the same outcome evidence behind it.
Read the guide
Unsure if you are eligible for weightloss medication?
Fill the simple form below to know your eligibility.